The @antv Ecosystem Was Compromised with Shai-Hulud Malware, 300+ Packages Affected OX Security
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
